Parvinen I, Helenius H, Pylkkänen L, Anttila A, Immonen-Räihä P, Kauhava L, Räsänen O, Klemi P J
Finnish National Fund for Research and Development, Helsinki, Finland.
J Med Screen. 2006;13(1):34-40. doi: 10.1258/096914106776179845.
The aim of this study was to assess the effects of service screening mammography on breast carcinoma incidence and refined mortality among women aged 55-69 at entry in three cities employing different screening policies.
Since 1987, the city of Turku, Finland, has provided service screening mammography for women aged 55-69 at entry (in 1987), and Tampere provided screening for women aged 55-59 at entry, whereas Helsinki did not screen any of these age groups. The incidence of breast carcinoma during the screening period 1987-97 in women born in 1918-32 (1918-22, 1923-27, 1928-32) was compared with incidence during the pre-screening period 1976-86 in women born in 1907-21 (1907-11, 1912-16, 1917-21) in each city. The follow-up for mortality was four years longer.
Breast carcinoma incidence was 31-38% higher in the screening period in all three cities irrespective of screening. In breast carcinoma mortality, no significant changes were seen in Helsinki or Tampere. In Turku, a 36% mortality reduction (relative risk [RR] 0.64; 95% confidence interval [CI] 0.47-0.88; P=0.007) in the whole study population and a 47% reduction in women aged 65-69 at entry (RR 0.53; 95% CI 0.28-0.99; P=0.047) were seen.
The incidence of breast carcinoma increased in all study cities irrespective of screening. The comprehensive screening programme in Turku including women aged 55-69 at entry was associated with a significant reduction in breast carcinoma mortality. The pronounced decrease in mortality in the oldest age group (65-69 years at entry) also indicated that women of this age group greatly benefit from mammography screening.
本研究旨在评估在三个采用不同筛查政策的城市中,对55 - 69岁初筛女性进行乳腺钼靶筛查服务对乳腺癌发病率和精确死亡率的影响。
自1987年起,芬兰图尔库市为1987年初筛时年龄在55 - 69岁的女性提供乳腺钼靶筛查服务,坦佩雷为初筛时年龄在55 - 59岁的女性提供筛查,而赫尔辛基未对这些年龄组中的任何女性进行筛查。将1918 - 32年出生(1918 - 22年、1923 - 27年、1928 - 32年)的女性在1987 - 97年筛查期间的乳腺癌发病率与每个城市中1907 - 21年出生(1907 - 11年、1912 - 16年、1917 - 21年)的女性在1976 - 86年筛查前期间的发病率进行比较。死亡率随访时间延长了四年。
在所有三个城市中,无论是否进行筛查,筛查期间的乳腺癌发病率均高出31% - 38%。在乳腺癌死亡率方面,赫尔辛基和坦佩雷未观察到显著变化。在图尔库,整个研究人群的死亡率降低了36%(相对风险[RR] 0.64;95%置信区间[CI] 0.47 - 0.88;P = 0.007),初筛时年龄在65 - 69岁的女性死亡率降低了47%(RR 0.53;95% CI 0.28 - 0.99;P = 0.047)。
无论是否进行筛查,所有研究城市的乳腺癌发病率均有所上升。图尔库针对初筛时年龄在55 - 69岁女性的全面筛查计划与乳腺癌死亡率的显著降低相关。最高年龄组(初筛时65 - 69岁)死亡率的显著下降也表明该年龄组的女性从乳腺钼靶筛查中获益巨大。